Evidence map›Paper›PMID 12381813›Full record

ArticleThe Journal of physiology2002

Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na(+) current and delayed rectifier K(+) current in rat sensory neurons.

Y H Zhang, M R Vasko, G D Nicol

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 156 citations in OpenAlex.

  1. Short Cationic ACTH-Related Peptides Can Modulate the NaInternational journal of molecular sciences · 2026
    Article
  2. Metabolism of sphingolipids in a rat spinal cord stenosis model.Biochemistry and biophysics reports · 2025
    Article
  3. Emerging role of macrophages in neuropathic pain.Journal of orthopaedic translation · 2025
    Review
  4. Article
  5. Dysregulation of sphingolipid metabolism in pain.Frontiers in pharmacology · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Sodium channels and pain: from toxins to therapies.British journal of pharmacology · 2018
    Review
  15. Swedish Nerve Growth Factor Mutation (NGFThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Functional Diversity of Neurotrophin Actions on the Oculomotor System.International journal of molecular sciences · 2016
    Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Y H ZhangDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, IN 46202, USA.
M R Vasko
G D Nicol
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

ACTIONS OF PROINFLAMMATORY CYTOKINES ON SENSORY NEURONSR01NS037951 · NINDS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI NICOL, GRANT D · 1999 to 2002
$900k
NINDS NIH HHS NS 37951
6 · The paper itself

Abstract

Because nerve growth factor (NGF) is elevated during inflammation and is known to activate the sphingomyelin signalling pathway, we examined whether NGF and its putative second messenger, ceramide, could modulate the excitability of capsaicin-sensitive adult and embryonic sensory neurons. Using the whole-cell patch-clamp recording technique, exposure of isolated sensory neurons to either 100 ng ml(-1) NGF or 1 microM N-acetyl sphingosine (C2-ceramide) produced a 3- to 4-fold increase in the number of action potentials (APs) evoked by a ramp of depolarizing current in a time-dependent manner. Intracellular perfusion with bacterial sphingomyelinase (SMase) also increased the number of APs suggesting that the release of native ceramide enhanced neuronal excitability. Glutathione, an inhibitor of neutral SMase, completely blocked the NGF-induced augmentation of AP firing, whereas dithiothreitol, an inhibitor of acidic SMase, was without effect. In the presence of glutathione and NGF, exogenous ceramide still enhanced the number of evoked APs, indicating that the sensitizing action of ceramide was downstream of NGF. To investigate the mechanisms of action for NGF and ceramide, isolated membrane currents were examined. Both NGF and ceramide facilitated the peak amplitude of the TTX-resistant sodium current (TTX-R I(Na)) by approximately 1.5-fold and shifted the activation to more hyperpolarized voltages. In addition, NGF and ceramide suppressed an outward potassium current (I(K)) by approximately 35 %. Ceramide reduced I(K) in a concentration-dependent manner. Isolation of the NGF- and ceramide-sensitive currents indicates that they were delayed rectifier types of I(K). The inflammatory prostaglandin, PGE(2), produced an additional suppression of I(K) after exposure to ceramide (approximately 35 %), suggesting that these agents might act on different targets. Thus, our findings indicate that the pro-inflammatory agent, NGF, can rapidly enhance the excitability of sensory neurons. This NGF-induced sensitization is probably mediated by activation of the sphingomyelin signalling pathway to liberate ceramide(s), wherein ceramide appears to be the second messenger involved in modulating neuronal excitability.

Indexed as

Potassium Channels, Voltage-GatedAnimalsCells, CulturedCeramidesDelayed Rectifier Potassium ChannelsDinoprostoneElectric ConductivityEnzyme InhibitorsMaleNerve Growth FactorNeurons, AfferentPotassium ChannelsRatsRats, Sprague-DawleySecond Messenger SystemsSodium ChannelsCeramidesDelayed Rectifier Potassium ChannelsDinoprostoneEnzyme InhibitorsNerve Growth FactorPotassium ChannelsPotassium Channels, Voltage-GatedSodium ChannelsSphingomyelin PhosphodiesteraseTetrodotoxin

Identifiers

PMID12381813
PMCPMC2290585
OpenAlexW2097482307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.